A paper in World Heart Federation’s journal Global Heart advocates for the inclusion of ultrasound in medical education programs to fully realize its benefits as early as possible. The review is by J. Christian Fox, professor of clinical emergency medicine and director of instructional ultrasound, University of California Irvine School of Medicine and colleagues.

Claret Medical Inc. received CE marking for the Sentinel Cerebral Protection System (CPS) for embolic protection during transcatheter aortic valve replacement (TAVR). 

Sapien 3, TAVR, CE mark, european approval

Edwards Lifesciences Corp. received CE marking for its Edwards Sapien 3 transcatheter aortic valve.
Experts presented six-month LEVANT 2 trial results for C. R. Bard Inc.’s Lutonix drug coated balloon (DCB) and provided updates on the ongoing Lutonix Below the Knee (BTK) Clinical Trial at the Leipzig Interventional Course (LINC) in Leipzig, Germany.
 

Prof. Richard Schilling implanted St. Jude Medical Inc.’s Nanostim retrievable leadless pacemaker at St. Bartholomew’s Hospital, London.

Infraredx Inc.’s TVC Imaging System will be manufactured and distributed in Japan by Nipro Corp. Infraredx intends to commercialize the TVC Imaging System in Japan, China, Korea and other Asia Pacific markets.

BioLeonhardt, a Leonhardt Ventures company based in Los Angeles, unveiled its implantable stem cell pump at the 9th Annual Cell Therapy for Cardiovascular Disease meeting at Columbia University, Jan. 23, 2014.

An Effectiveness and Cost of ICD Follow-Up Schedule with Telecardiology (ECOST) study indicated the Biotronik Home Monitoring may reduce follow-up costs in patients with implantable defibrillators (ICDs).

The Society for Healthcare Epidemiology of America (SHEA), an infection control organization, issued voluntary recommendations regarding physician attire in Infection Control and Hospital Epidemiology. White coats, neckties, and wrist watches can become contaminated and may potentially serve as vehicles to carry germs from one patient to another.

CorMatrix Cardiovascular Inc. received a patent for an augmented injectable extracellular matrix (ECM) bioscaffold. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now